Cano Health (CANO) Misses Q3 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CANO Hot Sheet
Join SI Premium – FREE
Cano Health (NYSE: CANO) reported Q3 EPS of ($0.09), $0.08 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $526.8 million versus the consensus estimate of $440.51 million.
GUIDANCE:
Cano Health sees FY2021 revenue of $2.6-2.7 billion.
For earnings history and earnings-related data on Cano Health (CANO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viemed Healthcare, Inc. (VMD) Misses Q3 EPS by 2c; updates guidance
- Myriad Genetics (MYGN) Tops Q3 EPS by 9c ; Offers Guidance
- Veracyte (VCYT) Tops Q3 EPS by 10c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
